Solara Active Pharma Sciences inks pact with SeQuent Scientific

24 Sep 2018 Evaluate

Solara Active Pharma Sciences has entered into a business transfer agreement with SeQuent Scientific for sale of API facility at Mahad. The total consideration for the unit would be Rs 46.40 crore. The company has decided to hive-off Mahad unit as it is not aligned to multi product and US focused business of the company.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

557.95 -1.05 (-0.19%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×